The Visible Organ

I run twice a week through the Las Vegas wetlands, an hour each time. On the weekend I go in the morning, starting around 9 or 10, in a t-shirt, a hat and sunglasses. During the week I go at sunset, in a t-shirt. Occasionally the shirt comes off.

Back home: Native in the shower, Blueprint after it as an experiment, Honest when the rest of my body needs lotion. La Roche-Posay and a Jack Black lip balm in the travel bag. Everything except the lip balm passed Yuka, the app that scores a product’s ingredients from its barcode, before it earned a place on the shelf.

My rule for the sun is shorter: “as long as it doesn’t burn, it’s good enough.”

I don’t wear sunscreen on runs unless the sun feels like it’s burning, and I avoid running in peak sunshine. The hat is the one thing I never skip: I’ve had sunstroke before. The ingredient lists get an app, while the exposure gets a sensation, and I chose it that way knowing it isn’t a perfect metric.

Skin is the one organ I can inspect in a mirror, and the part of mine that carries the most risk is the part I can’t see. My upper back is covered by a dense black-and-grey tattoo, with moles and freckles around both shoulders and no margins left around them.

Healthy skin is measurable. Dermatologists assess the barrier through transepidermal water losstransepidermal water lossThe amount of water that evaporates through the skin to the air, used as a measure of how well the skin barrier holds moisture in., the water escaping across the surface, along with hydration of the outer layer and surface pH. Elasticity and sebum are the other usual measurements.

A face looks moisturized for an hour after a cream goes on, and that tells me nothing about water loss the next morning. My shelf promises appearance and lists ingredients. It doesn’t show me a barrier number.

The outer layer, the stratum corneumstratum corneumThe outermost layer of the skin, made of flattened dead cells that form the main barrier against water loss and outside irritants., renews on an age-dependent schedule, not the “every 28 days” that skincare copy repeats. Grove’s forearm data, summarized in a 2024 Journal of Cosmetic Science review, put turnover at about 20 days in people under 35 and about 28 days in people over 60.

The sun shows up in visible aging more clearly than any active on my shelf. Flament et al. scored 22 facial aging signs in 298 Caucasian women aged 30–78 in Montpellier and classed about 80% of them as sun-affected. The authors work for L’Oréal and the study had no unexposed control group, so the 80% describes which signs the sun touches, not how much of a face’s aging it causes. The one class of active with real evidence against sun-aged skin, retinoidsretinoidsVitamin A derivatives used on skin to treat acne and signs of sun-aged skin., isn’t on my shelf.

Skin reports on the rest of the body. In Christensen et al.’s study of 1,826 Danish twins aged 70 and older, how old someone looked in a photograph predicted survival after adjusting for chronological age, and perceived age correlated with telomere length. The face carried information the birth certificate didn’t.

The causality runs one way. A photograph captures the health underneath; a moisturizer that makes the photograph look younger doesn’t reach back and change it. Longevity marketing borrows this study more often than it reads it.

Xanthelasma, the yellowish deposits around the eyelids, tracked with heart attacks and ischemic heart diseaseischemic heart diseaseHeart disease caused by narrowed arteries that reduce blood flow to the heart muscle. in the Copenhagen City Heart Study, independently of blood lipids. Removing the deposit leaves the arteries as they were.

Severe psoriasispsoriasisA chronic inflammatory skin condition in which skin cells build up quickly and form red, scaly patches. raises the risk of heart attack, most sharply in young patients, according to Gelfand et al. Acanthosis nigricans, darkened velvety skin in body folds, often accompanies insulin resistanceinsulin resistanceA state in which the body’s cells respond poorly to insulin, so blood sugar is harder to regulate.. None of these is a diagnosis from a bathroom mirror. Together they make it hard to treat skin as a cosmetic surface sitting on top of everything else.

Two bands of ultraviolet light matter here. UVBUVBThe shorter-wavelength band of ultraviolet light from the sun, the main cause of sunburn. is absorbed mostly in the epidermisepidermisThe outer layers of the skin, above the dermis. and causes burning. UVAUVAThe longer-wavelength band of ultraviolet light from the sun, which reaches deeper into the skin than UVB. penetrates deeper into the dermisdermisThe layer of skin beneath the epidermis, containing blood vessels, nerves, collagen and hair follicles.. Both damage DNA. My rule treats the burn as the signal that protection matters, and it’s worth knowing what that signal misses.

The damage starts well before the burn. Burren et al. found pyrimidine dimers, the signature UV lesion in DNA, and activation of p53, the cell’s DNA-damage alarm, in human skin after doses of simulated sunlight too small to redden it. Tanning runs on that same alarm, as Cui et al. showed in mice, so a tan is the skin reacting to damage that has already happened. My skin doesn’t have to hurt for something to have happened to it.

UV also suppresses immunity below the burn threshold. In human volunteers, sub-burn simulated sunlight weakened the skin’s immune reaction to nickel, an allergen it already knew, and the effect grew with the dose. A rule built on discomfort can’t register any of this.

The damage doesn’t stop when I go inside, either. Premi et al. found that these DNA lesions kept forming for more than 3 hours after UVA exposure ended in cultured pigment cells, driven by excited melaninmelaninThe pigment that gives skin its color and absorbs ultraviolet light.; in mice, levels were still climbing at 2 hours. These “dark” lesions haven’t been measured the same way in human skin.

A base tan buys very little. In one small trial, two weeks of repeated sub-burn exposure gave skin types II and IIIskin types II and IIICategories on the Fitzpatrick scale, which groups skin by its reaction to sun: fair skin that burns easily and tans minimally or gradually. a protection factorprotection factorA number describing how much longer protected skin can stay in the sun before reddening compared with unprotected skin. of roughly 1.4–2.3. Far from the typical (SPF) 30.

Burning still counts, and it counts most early. In the Nurses’ Health Study II, Wu et al. linked 5 or more blistering sunburns between ages 15 and 20 to about 80% higher melanomamelanomaThe most dangerous form of skin cancer, arising in the pigment-producing cells of the skin. risk. Cumulative adult exposure behaved differently: it tracked with basal and squamous cell cancersbasal and squamous cell cancersThe two most common types of skin cancer, which are far less likely than melanoma to spread to other organs., and not with melanoma.

Sunlight isn’t simply poison, and the best evidence for that comes from Sweden. Lindqvist et al. followed 29,518 women for about 20 years; compared with the highest-exposure group, sun avoiders lived 0.6–2.1 years less, mostly through cardiovascular and other non-cancer deaths. Exposure was self-reported, women who seek the sun may be healthier in ways no adjustment captures, and Swedish latitude is a long way from a desert summer. I read it as a reason not to hide from daylight. How much daylight is too much, hard to gage when being outside.

So the burn is a crude metric, and I use it with that in view. The DNA damage, the immune effect and the after-dark lesions all happen below it. What I get in exchange is a few hours a week outdoors without covering myself head to toe or coating every exposed inch before I leave the house. The hat and sunglasses aren’t part of the trade; the childhood sunstroke settled that. My neck, ears and forearms take whatever an hour of weekend morning delivers.

The other half of the trade is a bet on what happens after the sun. Melanoma deaths have been falling since the newer drugs arrived, detection keeps getting better, and a skin cancer found early is usually a small excision. I’m betting that society’s ability to see skin cancer early and treat it keeps outrunning the damage I accept. That bet has one weak point, and it sits on my back.

Between 1975 and 2014, US melanoma incidenceincidenceThe number of new cases of a disease diagnosed in a population over a given period. rose roughly sixfold in White men and fourfold in White women. Some of that rise is real disease and some of it is more looking. Adamson, Suarez and Welch used Black patients, whose incidence barely moved, as a comparison group and estimated that about 60% of melanomas diagnosed in White men and 59% in White women in 2014 were overdiagnosedoverdiagnosedDiagnosed with a condition that would never have caused symptoms or harm during the person’s lifetime.: real lesions under the microscope that would never have harmed the person.

That estimate depends on its modelling assumption, and other dermatologists dispute how much of the rise detection can explain. The diagnoses are real lesions; the curve still overstates how fast dangerous disease is growing.

US melanoma deaths among White people fell about 18% from 2013 to 2016, after rising 7.5% over the previous 27 years. Berk-Krauss et al. tied the drop to new immunotherapiesimmunotherapiesTreatments that help the body’s immune system recognize and attack cancer cells. and targeted drugs for metastatic disease. The age pattern is shifting too. Paulson et al. found incidence fell between 2006 and 2015 among Americans aged 10–29 while it kept rising after 40, and Australia, where sun-protection campaigns started decades earlier, shows the same decline in younger people.

Melanoma hasn’t become harmless. The American Cancer Society projects about 112,000 invasive melanomas and 8,510 deaths in the US in 2026.

And the location matters for me specifically. In US cancer registry data analyzed by Yuan et al., the trunktrunkThe torso, meaning the chest, abdomen and back, as opposed to the head and limbs. was the most common melanoma site in White men, 39% of cases. That is where my tattoo is.

My tattoo is a large circle across the upper back. It’s about six years old.

I already treat this skin carefully in one place. In front of my red-light panel I face forward, because dark ink can absorb near-infrared light and heat up, and I’d rather keep that risk at zero than argue about it. The sun, with far better evidence of what it does to skin, gets the burn rule on the days the shirt comes off.

Those days are rare, and short when they happen. Most of the time a t-shirt covers my back, so the case for this skin isn’t today’s dose. It’s the moles already there, the sun it has already had, and the fact that I can’t see any of it.

Moles, grains de beauté, are the strongest visible risk factor for melanoma. Gandini et al.’s meta-analysismeta-analysisA study that statistically combines the results of several earlier studies to produce one overall estimate. put the risk at about seven times higher, a relative riskrelative riskThe chance of an outcome in one group divided by the chance in a comparison group, where 1 means no difference. of 6.9, for people with 101–120 common moles compared with fewer than 15, and found a similar jump with atypical moles. I don’t know my count. I just know that I have many.

Watching the existing moles covers less than I assumed. Pampena et al.’s meta-analysis classed 29.1% of melanomas as likely arising from a pre-existing mole and 70.9% as arising on skin that had no mole before. Most melanomas are new spots, and new spots are exactly what dense ink makes hard to notice.

The ink also gets in the way of the person looking. A 2014 Australian Family Physician case discussion said dark tattoo ink may mask some of the signs dermatologists read through a dermatoscope, the lit magnifier they press against a mole, and that detection is harder in dark tattoos than in light ones. A 2025 review in the Dermatology Online Journal counted 43 published melanoma cases inside tattoo pigment, 35 of them invasive, and the authors read their thickness as a sign that diagnosis came late. Case reports can’t give a rate. They do show what the failure looks like.

I left no margins around my moles.

The cancer risk from the ink itself is much weaker than the headlines suggest. Pigment and heavy metals do travel to the lymph nodeslymph nodesSmall bean-shaped glands that filter fluid from the body’s tissues and hold immune cells., as Schreiver et al. showed in cadaver tissue, but no harm from that has been shown. A Swedish study reported a lymphomalymphomaA cancer of the lymphatic system, which is part of the immune system. signal whose confidence intervalconfidence intervalThe range of values that is likely to contain the true effect, given the data. An interval that includes 1 means the result may be due to chance. crossed 1, and a Danish twin study linked tattoos larger than a palm to skin cancer and lymphoma on small numbers, with no data on sun exposure. A 2025 meta-analysis of four studies found no association with non-Hodgkin lymphoma at all.

On my shoulder there’s also a keloid. A keloid is a scar that keeps growing past the edges of the original injury and doesn’t regress; a hypertrophic scar stays inside the wound. Ekstein et al.’s review places keloids on high-tension skin like the chest and upper back, often after something minor: acne, folliculitis, a vaccination.

The artist who called me “little jesus” for how fast I healed would enjoy this. I looked for a link between fast healing and keloids and found none; keloids come from healing that is abnormal and prolonged. A fast healer with a scar that won’t stop growing is a coincidence.

Screening itself has thinner evidence than I expected. The US Preventive Services Task Force concluded in 2023 that the evidence is insufficient to judge clinician skin exams in asymptomatic adults. That is not a recommendation against them, and it explicitly excludes people with a history of skin cancer or already under high-risk surveillance. The statement is about populations.

Overdiagnosis and late diagnosis are different failures, and I’m exposed to the second. The 60% estimate describes lesions found in people who get looked at often, lesions that would never have harmed them. The tattoo cases describe the opposite: tumors thick enough that the authors read them as caught late. A population can be over-screened on average while one person, with many moles and a patch of ink that hides new spots, is under-screened.

Drinking more water does little for skin. Akdeniz et al.’s systematic reviewsystematic reviewA structured search and summary of all the studies that meet set criteria on a question, rather than a selection of them. found only 6 studies, with possible gains in outer-layer hydration concentrated in people who drank too little to begin with; Palma et al.’s study of 49 women found the same pattern. Correcting a deficit helps. Past that point, more water doesn’t keep improving the skin.

I put the Blueprint serum and moisturizer on right after the shower, which matches what dermatologists advise. The American Academy of Dermatology’s eczema guidance is warm water, 5–10 minutes, and moisturizer while the skin is still damp; Mayo Clinic says within 3–5 minutes of bathing. I found no trial behind the popular “3-minute rule”, and no high-level evidence for any particular bath length.

Washing has a cost. In Voegeli’s 15-person forearm study, soap and warm water, and to a lesser degree water alone, weakened barrier measurements, with tentative evidence that the effect builds with frequency.

How often to shower has no settled answer. Harvard Health says several showers a week is plenty for most people; some dermatologists advise daily.

Also, hard water is mostly reputation. In a randomized trial of 336 children with eczema, a water softener added nothing over usual care.

Weather acts on skin in narrower ways than the beauty aisle implies. Cold can trigger cold urticaria, hives on chilled skin. Heat can cause heat rash, sweat trapped under the surface. Dry winter air is widely reported to make eczema worse, though I couldn’t find strong trial evidence for it.

Heat raises one tattoo-specific anecdotal question. In Luetkemeier’s 2017 study of 10 men, tattooed skin produced about half the sweat of clear skin when sweating was triggered with a drug delivered through the skin. A 2022 exercise study of 33 people, funded by Gatorade, found no difference in local sweat rate.

Start with the instrument. Yuka’s own help page says a cosmetic’s score is set by its single highest-risk ingredient: one high-risk ingredient caps the score below 25 out of 100. A good score means no ingredient on Yuka’s list was found. It says nothing about benefit, and nothing about a product I only open a few times a year.

Fragrance is the ingredient most likely to cause a contact allergycontact allergyAn immune reaction in which skin touching a substance becomes red, itchy and inflamed.. The EU Scientific Committee on Consumer Safety puts fragrance allergy at 1–3% of the general population, and Frosch et al. found 6.9% of patients patch-tested across 12 European countries reacted to the standard fragrance mix. The Native face cleanser has never irritated my skin, so for me the risk stays theoretical.

Also, “paraben-free” is a marketing claim. The same European committee considers methyl- and ethylparaben safe at the permitted concentrations. I’d been counting the missing ingredient as a point in the product’s favor.

The Native aluminum-free deodorant comes out when I’m social. The American Cancer Society finds no strong evidence linking aluminum antiperspirants to breast cancer, and the Alzheimer’s Association lists the aluminum link as a myth. Aluminum-free is a preference, and it needs no health claim attached.

Blueprint is the experimental part of my shelf. It supplies the serum and moisturizer, and I own its cleanser too. The serum’s headline ingredient, SFC, is a proprietary molecule, disodium succinoyl farnesylcysteine. Blueprint’s page cites no study for it or for NMN, nicotinamide mononucleotide, and gives no basis for its claim that SFC is “5x more powerful than niacinamideniacinamideA form of vitamin B3 widely used in skincare.”. The NMN research I could find is oral, cellular or animal. None of it is topical in humans as of today.

Sunscreen is the one product category on this shelf with randomized outcome data. In the Nambour trial in Queensland, daily sunscreen didn’t significantly reduce first new skin cancers overall, but it cut squamous cell tumors by about 40%. At follow-up, the daily group had half the melanomas, with a confidence interval of 0.24–1.02 that just crosses 1, and fewer invasive melanomas, 3 against 11. Hughes et al. found less photoaging in the same daily-use group.

The trial numbers assume the label dose. SPF is tested at 2 mg/cm², and Petersen and Wulf’s review puts typical real-world application at roughly 0.4–1 mg/cm². A large self-report survey found higher values, but most people, me included, get less protection than the bottle says.

The trial’s protection belongs to a daily habit. Mine is occasional, applied below the label dose, and triggered by a sensation I picked on purpose. The Nambour results describe someone else’s routine, and I’ve accepted that.

The one addition I’m considering is a retinoid at night, the class missing from this shelf. A 2023 Journal of Drugs in Dermatology review found prescription topical retinoids the most potent option for sun-aged skin, limited by irritation, with clinical data for over-the-counter versions generally lacking. That makes it a conversation with a dermatologist, and I haven’t had it yet.